Aniracetam is a nootropic agent of the racetam family.
Aniracetamis one of the main ampakines, it served a model for many newer and more potent AMPA modulators. Aniracetam itself has been used in the treatment of strokes in Japan and Alzheimer's disease in Europe.
Aniracetam appears to have neurotrophic enhancing properties. Once absorbed in the gastrointestinal tract aniracetam is almost entirely metabolized, only about 0.2% reaches systemic circulation, much less than what would be necessary for significant AMPA receptor modulation.It may be possible to retain aniracetam ampakine effects by taking it sublingually, but that method of administration isn't well-tested. Aniracetam, when dosed correctly, is very efficient at giving the user a 'flow' like state where focusing becomes much easier.
choosing a selection results in a full page refresh